Hasan Jafri - Jun 27, 2024 Form 4 Insider Report for Aridis Pharmaceuticals, Inc. (ARDS)

Role
Chief Medical Officer
Signature
/s/ Hasan Jafri
Stock symbol
ARDS
Transactions as of
Jun 27, 2024
Transactions value $
$0
Form type
4
Date filed
6/28/2024, 07:46 PM
Previous filing
Sep 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDS Stock options Award $0 +250K +188.69% $0.00 382K Jun 27, 2024 Common Stock 250K $0.06 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.